Other OTC - Delayed Quote USD

Bellerophon Therapeutics, Inc. (BLPH)

0.0586 +0.0075 (+14.68%)
At close: 2:13 PM EDT

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
AMIN NASEEM M.D. Director Stock Award(Grant) Jun 7, 2023 291,865
DEKKER MARTIN Officer Conversion of Exercise of derivative security Dec 9, 2022 17,666
FERNANDES PETER Officer Conversion of Exercise of derivative security Dec 9, 2022 22,515
KIM BOBAE Officer Sale May 18, 2023 1,723
LACCONA NICHOLAS Chief Financial Officer Conversion of Exercise of derivative security Dec 9, 2022 12,470
NEW MOUNTAIN INVESTMENTS II L L C Beneficial Owner of more than 10% of a Class of Security Sale Mar 18, 2021 --
PEACOCK JONATHAN M Director Stock Award(Grant) Mar 31, 2021 157,033
PUISSANCE CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security Sale Oct 13, 2023 --
PUISSANCE CROSS-BORDER OPPORTUNITIES V LLC Beneficial Owner of more than 10% of a Class of Security Stock Award(Grant) Apr 26, 2021 --
SHAH PARAG SURESH Officer Conversion of Exercise of derivative security Dec 9, 2022 17,666

Related Tickers